Hepatitis C virus infection and autoimmunity

https://doi.org/10.1016/S0049-0172(97)80005-4Get rights and content

Abstract

Hepatitis C virus (HCV) infection has been associated with a plethora ofimmune and autoimmune perturbations. We review serological and clinical autoimmune manifestations associated with HCV infection, discuss treatment regimens for HCV-related autoimmune diseases, and present a framework for understanding HCV-associated autoimmune disease by performing a computerized literature search from which representative articles were used and referenced. The immune response to HCV may include the development of cryoglobulins, rheumatoid factor, antinuclear antibodies (ANA), anticardiolipin, antithyroid, anti-liver/kidney/microsomal antibodies (anti-LKM), as well as HCV/anti-HCV immune complex formation and deposition. HCV infection is a significant cause of mixed essential cryoglobulinemia, which may then be complicated by cryoglobulinemic glomerulonephritis, vasculitis, or neuropathy. It has also been associated with membranous and membranoproliferative glomerulonephritis. Subsets of autoimmune hepatitis patients are infected with HCV and evidence suggests that HCV is a causative agent of antithyroid antibodies and autoimmune thyroid disease. Although cause-and-effect remain to be proved, there are reports of HCV infection preceding or coincident with polyarthritis, rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and polymyositis/dermatomyositis (PM/DM). HCV-infected patients also have a high incidence of sialoadenitis, and reports of low-grade lymphoproliferative malignancies have emerged. However, HCV is not a major causative factor for most autoimmune diseases. Optimal treatment for HCV-related autoimmune disease remains to be determined. Interferon alpha (IFNα) has successfully reduced viremia/transaminitis, cryoglobulins, proteinuria, and nephritis, but recurrent disease manifestations are frequent after discontinuation of therapy, Moreover, IFNα may precipitate or exacerbate autoimmune disease symptoms. HCV-related autoimmune disease also has been treated successfully with corticosteroids, azathioprine, and cyclophosphamide, although HCV viremia persists and may worsen.

References (125)

  • AlterM.J. et al.

    The natural history of community acquired hepatitis C in the United States

    N Engl J Med

    (1992)
  • AlterH.J.

    To C or not to C: these are the questions

    Blood

    (1995)
  • SorrellM.F.

    Clinical crossroads: a 47 year old man with asymptomatic hepatitis C infection

    JAMA

    (1996)
  • ScotiniotisI. et al.

    Hepatitis C: diagnosis and treatment

    J Gen Intern Med

    (1995)
  • GumberS.C. et al.

    Hepatitis C: a multifaceted disease: review of extrahepatic manifestations

    Ann Intern Med

    (1995)
  • BonE. et al.

    Rheumatic manifestations of chronic hepatitis C and response to treatment with interferon alpha

    Revue du Rheumatisme, Edition Francaise

    (1994)
  • NishikaiM. et al.

    Dermatomyositis following infection with hepatitis C virus

    J Rheumatol

    (1994)
  • HorsmansY. et al.

    Symptomatic myopathy in hepatitis C infection without interferon therapy

    Lancet

    (1995)
  • UenoY. et al.

    Hepatitis C infection and polymyositis

    Lancet

    (1995)
  • WeidensaulD. et al.

    Polymyositis, pulmonary fibrosis, and hepatitis C

    Arthritis Rheum

    (1995)
  • MartinP.

    Hepatitis C genotypes: The key to pathogenicity?

    Ann Intern Med

    (1995)
  • KozielM.J.

    Immunology of viral hepatitis

    Am J Med

    (1996)
  • WillemsM. et al.

    Hepatitis C virus and its genotypes in patients suffering from chronic hepatitis C with or without a cryoglobulinemic related syndrome

    J Med Virol

    (1994)
  • De MedinaM. et al.

    Hepatitis C: diagnostic assays

    Semin Liver Dis

    (1995)
  • MonteverdeA. et al.

    Reliability of immunoassays for anti-HCV antibodies (ELISA and RIBA 2) in patients with essential mixed cryoglobulinemic

    Clin Exp Rheumatol

    (1993)
  • FreniM.A. et al.

    Focal lymphocytic aggregates in chronic hepatitis C: occurrence, immunohistochemical characterization, and relations to markers of autoimmunity

    Hepatology

    (1995)
  • CzajaA.J. et al.

    Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis

    Gastroenterology

    (1993)
  • SansonnoD. et al.

    Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemic

    Hepatology

    (1995)
  • SinicoR.A. et al.

    Identification of glomerular immune deposits in cryoglobulinemic glomerulonephritis

    Kidney Int

    (1988)
  • SzymanskiI.0. et al.

    Electron microscopic and immunochemical studies in a patient with hepatitis C virus infection and mixed cryoglobulinemic type II

    Am J Clin Pathol

    (1994)
  • PawlotskyJ.M. et al.

    Extrahepatic immunologic manifestations in chronic hepatitis C virus serotypes

    Ann Intern Med

    (1995)
  • CzajaA.J. et al.

    Significance of human leukocyte antigens DR3 and DR4 in chronic viral hepatitis

    Dig Dis Sci

    (1995)
  • VentoS. et al.

    Discordant manifestations of hepatitis C in monozygotic twin

    N Engl J Med

    (1995)
  • CacciarelliT.V. et al.

    Immunoregulatory cytokines in chronic hepatits C virus infection: preand posttreatment with interferon alfa

    Hepatology

    (1996)
  • CliffordB.D. et al.

    High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C

    Hepatology

    (1995)
  • KawamotoH. et al.

    Autoimmune responses as assessed by hypergammaglobulinemia and the presence of autoantibodies in patients with chronic hepatitis C

    Acta Medina Okayama

    (1993)
  • PrietoJ. et al.

    Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome

    Hepatology

    (1996)
  • AbuafN. et al.

    Non-organ specific autoantibodies associated with chronic C virus hepatitis

    J Hepatol

    (1993)
  • MuratoriL. et al.

    Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease

    Gut

    (1995)
  • PreziatiD. et al.

    Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon-alpha 2a

    Eur J Endocrinol

    (1995)
  • BoadasJ. et al.

    Prevalence of thyroid autoantibodies is not increased in blood donors with hepatitis C virus infection

    J Hepatol

    (1995)
  • ImagawaA. et al.

    Autoimmune endocrine diseased induced by recombinant interferon alpha therapy for chronic active type C hepatitis

    J Clin Endorinol Metab

    (1995)
  • GorevicP.D. et al.

    Mixed cryoglobulinemia: clinical aspects and long term follow-up of 40 patients

    Am J Med

    (1980)
  • FerriC. et al.

    Antibodies to hepatitis C in patients with mixed cryoglobulinemia

    Arthritis Rheum

    (1991)
  • MiaianiR. et al.

    Hepatitis C virus infection in patients with essential mixed cryoglobulinemia

    Ann Intern Med

    (1992)
  • CacoubP. et al.

    Mixed cryoglobulinemia and hepatitis C virus

    Am J Med

    (1994)
  • KarlsbergP.L. et al.

    Cutaneous vasculitis and rheumatoid factor positivity as presenting signs of hepatitis C virus induced mixed cryoglobulinemia

    Arch Dermatol

    (1995)
  • DupinN. et al.

    Essential mixed cryoglobulinemia: a comparative study of dermatologic manifestations in patients infected or noninfected with hepatitis C virus

    Arch Dermatol

    (1995)
  • DaudM.S. et al.

    Chronic hepatitis C and skin diseases: a review

  • JohnsonR.J. et al.

    Renal manifestations of hepatitis C virus infection

    Kidney Int

    (1994)
  • Stehman-BreenC. et al.

    Hepatitis C associated glomerulonephritis

    Curr Opin Nephrol Hypertens

    (1995)
  • KhellaS.L. et al.

    Hepatitis C infection, cryoglobulinemia, and vasculitic neuropathy: treatment with interferon alta: case report and literature review

    Neurology

    (1995)
  • MisianiR. et al.

    Interferon alfa 2a therapy in cryoglobulinemia associated with hepatitis C virus

    N Engl J Med

    (1994)
  • LeveyJ.M. et al.

    Mixed cryoglobulinemia in chronic hepatitis C infection: a clinicopathologic analysis of 10 cases and review of recent literature

    Medicine

    (1994)
  • HarleJ.R. et al.

    Dramatic worsening of hepatic C virus-related cryoglobulinemia subsequent to treatment with interferon alfa

    JAMA

    (1995)
  • RocinoC. et al.

    Hepatitis C virus and membranous glomerulonephritis

    Nephron

    (1991)
  • YamabeH. et al.

    Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan

    J Am Soc Nephrol

    (1995)
  • JohnsonR.J. et al.

    Hepatitis-C virus-associated glomerulonephritis: effect of alpha interferon

    Kidney Int

    (1994)
  • JohnsonR.J. et al.

    Membranoproliferative glomerulonephritis associated with hepatitis C virus infection

    N Engl J Med

    (1993)
  • Garcia-ValdecasasJ. et al.

    Epidemiology of hepatitis C virus infection inpatients with renal disease

    J Am Soc Nephrol

    (1994)
  • Cited by (196)

    • Anti-rods/rings autoantibody and IMPDH filaments: an update after fifteen years of discovery

      2020, Autoimmunity Reviews
      Citation Excerpt :

      Among cirrhosis patients, there is a 1–5% annual risk of developing hepatocellular carcinoma and a 3–6% annual risk of hepatic decompensation, which leads to death in the following year in 15–20% of cases [37]. While HCV infection itself is not an autoimmune disorder, it has been associated with a variety of serological and clinical autoimmune manifestations, including ANA, rheumatoid factor, anti-cardiolipin, anti-thyroid, anti-smooth muscle, and anti-liver/kidney/microsomal autoantibodies [38–42]. It is often not clear why autoantibodies are generated against self-antigens.

    • Lupus Hepatitis and Autoimmune Hepatitis (Lupoid Hepatitis)

      2017, American Journal of the Medical Sciences
    • Viral Arthritis

      2016, Kelley and Firestein's Textbook of Rheumatology: Volumes 1-2, Tenth Edition
    • Hepatitis C virus antibodies in high risk juvenile onset systemic lupus erythematosus

      2016, Revista Brasileira de Reumatologia
      Citation Excerpt :

      In fact, none of our 15 patients with active disease (elevated SLEDAI index) revealed a positive test for anti-HCV in spite of previous report of false positive anti-HCV serology related to lupus activity.5,11,23 Additionally, HCV has also been associated to a high variety of extra hepatic manifestations including membranoproliferative glomerulonephritis, porphyria cutanea tarda, lychen planus and thyroiditis.4–9 The notable capacity of HCV to induce autoantibodies has aroused particular interests in the possible association between SLE and HCV chronic hepatitis.6

    View all citing articles on Scopus
    View full text